Cargando…

Molecular Signatures of Prostate Stem Cells Reveal Novel Signaling Pathways and Provide Insights into Prostate Cancer

BACKGROUND: The global gene expression profiles of adult and fetal murine prostate stem cells were determined to define common and unique regulators whose misexpression might play a role in the development of prostate cancer. METHODOLOGY/PRINCIPAL FINDINGS: A distinctive core of transcriptional regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blum, Roy, Gupta, Rashmi, Burger, Patricia E., Ontiveros, Christopher S., Salm, Sarah N., Xiong, Xiaozhong, Kamb, Alexander, Wesche, Holger, Marshall, Lisa, Cutler, Gene, Wang, Xiangyun, Zavadil, Jiri, Moscatelli, David, Wilson, E. Lynette
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684642/ https://www.ncbi.nlm.nih.gov/pubmed/19478945 http://dx.doi.org/10.1371/journal.pone.0005722

Ejemplares similares

Molecular Signatures of the Primitive Prostate Stem Cell Niche Reveal Novel Mesenchymal-Epithelial Signaling Pathways
por: Blum, Roy, et al.
Publicado: (2010)

TGF-β maintains dormancy of prostatic stem cells in the proximal region of ducts
por: Salm, Sarah N., et al.
Publicado: (2005)

Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis
por: Tsujimura, Akira, et al.
Publicado: (2002)

Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer
por: Sarkar, Purandar, et al.
Publicado: (2022)

Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer
por: Pascoe, Abigail C, et al.
Publicado: (2012)

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
por: Tsai, Harrison K., et al.
Publicado: (2017)

Prostatic Hypertrophy
por: Clinton, Marshall
Publicado: (1901)

Identifying prognostic signatures in the microenvironment of prostate cancer
por: Lu, Guoliang, et al.
Publicado: (2021)

Radiotherapy-Related Gene Signature in Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2022)

Integrative Epigenome Map of the Normal Human Prostate Provides Insights Into Prostate Cancer Predisposition
por: Wang, Tao, et al.
Publicado: (2021)

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer
por: Lin, Dong, et al.
Publicado: (2017)

Distinct urinary glycoprotein signatures in prostate cancer patients
por: Kawahara, Rebeca, et al.
Publicado: (2018)

DNA methylation signatures of Prostate Cancer in peripheral T-cells
por: Mehdi, Ali, et al.
Publicado: (2020)

Reference-free transcriptome signatures for prostate cancer prognosis
por: Nguyen, Ha T.N., et al.
Publicado: (2021)

A Novel Blood Proteomic Signature for Prostate Cancer
por: Muazzam, Ammara, et al.
Publicado: (2023)

Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China
por: Huang, Da, et al.
Publicado: (2020)

Akt isoforms differentially provide for chemoresistance in prostate cancer
por: Ma, Bo, et al.
Publicado: (2022)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
por: Drago, Denise, et al.
Publicado: (2021)

Identification of Pathogen Signatures in Prostate Cancer Using RNA-seq
por: Chen, Yunqin, et al.
Publicado: (2015)

Novel Prostate Cancer Biomarkers Derived from Autoantibody Signatures()
por: Schipper, Matthew, et al.
Publicado: (2015)

Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer
por: Myers, Jennifer S., et al.
Publicado: (2015)

Improvement in prediction of prostate cancer prognosis with somatic mutational signatures
por: Zhang, Shengping, et al.
Publicado: (2017)

A four gene signature predictive of recurrent prostate cancer
por: Komisarof, Justin, et al.
Publicado: (2016)

Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
por: Ostano, Paola, et al.
Publicado: (2020)

Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges
por: Doultsinos, Dimitrios, et al.
Publicado: (2021)

Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer
por: Ye, Yongkang, et al.
Publicado: (2023)

An anoikis-related gene signature for prediction of the prognosis in prostate cancer
por: Zhao, Xiaodong, et al.
Publicado: (2023)

Experimental identification of cancer driver alterations in the era of pan‐cancer genomics
por: Korenjak, Michael, et al.
Publicado: (2019)

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
por: Koreckij, T, et al.
Publicado: (2009)

Arum Palaestinum with isovanillin, linolenic acid and β-sitosterol inhibits prostate cancer spheroids and reduces the growth rate of prostate tumors in mice
por: Cole, Caitlin, et al.
Publicado: (2015)

Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer
por: Hudson, Robert S, et al.
Publicado: (2013)

An expression signature at diagnosis to estimate prostate cancer patients' overall survival
por: Peng, Z, et al.
Publicado: (2014)

A predictive signature for therapy assignment and risk assessment in prostate cancer
por: Bonci, Désirée, et al.
Publicado: (2015)

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
por: Kim, Yunee, et al.
Publicado: (2016)

A novel non-canonical Wnt signature for prostate cancer aggressiveness
por: Sandsmark, Elise, et al.
Publicado: (2016)

Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer
por: Priolo, Carmen, et al.
Publicado: (2015)

KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer
por: Zhang, Jun, et al.
Publicado: (2020)

Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma
por: Zhao, Hai‐Bo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m26f6rekga3ma9e1bpshneludm